Phytotox Limited
Records under this name other than patents Phytotox Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Phytotox Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,107,925 | Sodium channel blocker for treatment of loss of superficial sensitivity Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,623,886 | Phycotoxins and uses thereof Formerly held Term ended Term ended Jun 1, 2025 · From the USPTO record | Term ended | Term ended Jun 1, 2025 | From the USPTO record |
| US 8,377,951 | Transdermal administration of phycotoxins Formerly held Lapsed on the fee record Ended Feb 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 19, 2025 | From the USPTO record |
| US 8,889,681 | Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies Formerly held Term ended Term ended Nov 14, 2022 · From the USPTO record | Term ended | Term ended Nov 14, 2022 | From the USPTO record |
| US 9,301,958 | Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine Formerly held Term ended Term ended Nov 14, 2022 · From the USPTO record | Term ended | Term ended Nov 14, 2022 | From the USPTO record |
| US 8,871,763 | Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies Formerly held Lapsed on the fee record Ended Oct 28, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2022 | From the USPTO record |